
zzso zzso zzso is an zzso agent that, like zzso exhibits broad activity in solid zzso A phase I trial of zzso and zzso was zzso based on the demonstration of zzso zzso zzso 

Thirty-five patients zzso I) received zzso courses zzso zzso range, one to 14 courses) of treatment of zzso at doses of 1,000 and 1,250 zzso on days 1 and 8 and zzso at doses of zzso zzso 400, 500, and 600 zzso given 90 minutes after zzso on day zzso Courses were repeated every 3 zzso Because the day 8 dose of zzso was reduced or omitted in 57% of courses due to zzso 21 patients zzso zzso were treated on an alternate schedule, with zzso administered on day 8 rather than day zzso This group received 85 treatment courses zzso zzso range, one to 10 zzso 

The most common and zzso toxicity was zzso Other zzso included zzso fatigue, zzso and elevated zzso zzso The zzso dose was zzso zzso zzso for group I and zzso zzso for group zzso Thirteen objective responses were documented zzso cancer, zzso zzso 3; zzso lung cancer, zzso zzso 3; zzso zzso zzso 2; zzso zzso zzso zzso 2; zzso zzso zzso 1; breast cancer, zzso zzso 1; and zzso of unknown primary site, zzso zzso zzso zzso had no effect on the disposition of zzso 

The zzso combination is broadly active and warrants further zzso The sequence of zzso administered on days 1 and 8 with zzso administered on day 8 is better tolerated and is recommended for further study at doses of zzso zzso zzso 

